Premium Reports
Contact KLAS
 Download Report    Zoom in charts

Preferences

   Bookmark

Related Series

 No Related Series

 End chart zoom
McKesson Utilization Analytics 2023 McKesson Utilization Analytics 2023
* A page refresh may be necessary to see the updated image

McKesson Utilization Analytics 2023
Lowering Drug Expenditure & Improving Financial Efficiency

author - Jackson Tate
Author
Jackson Tate
author - Taelin Bryan
Author
Taelin Bryan
 
September 13, 2023 | Read Time: 1  minute

Healthcare in the US is uniquely inefficient, with costs generally growing faster than the overall economy. Consequently, lowering drug expenditure and improving financial efficiency are pivotal for health systems. To help customers maximize cost savings and discover revenue opportunities, McKesson’s Utilization Analytics solution integrates with drug purchasing, usage, patient administration, and reimbursement data as opposed to theoretical usage and payer contracts. This report offers a first look at customer experiences with this solution.

to see the full dataset.

If you don't have a login, getting started is easy.

Provider Organizations
Fill out our registration form to verify your organization.
HIT Companies
Contact a KLAS representative for plans and pricing.

Key Findings:

  1. McKesson Utilization Analytics Customer Experience: An Initial Look
  2. Points to Ponder
  3. McKesson: Company Profile at a Glance
  4. Solution Technical Specifications (provided by McKesson)
author - Kyle Chilton
Project Manager
Kyle Chilton
 Download Report

This material is copyrighted. Any organization gaining unauthorized access to this report will be liable to compensate KLAS for the full retail price. Please see the KLAS DATA USE POLICY for information regarding use of this report. © 2024 KLAS Research, LLC. All Rights Reserved. NOTE: Performance scores may change significantly when including newly interviewed provider organizations, especially when added to a smaller sample size like in emerging markets with a small number of live clients. The findings presented are not meant to be conclusive data for an entire client base.